The financial challenges pharmaceutical companies face when creating new medicines.
Antibiotic resistance is a complex, accelerating crisis requiring coordinated global action across health care, agriculture, industry, and governments. Without sustained investment in stewardship, surveillance, sanitation, and new treatments, the world risks a return to an era where minor infections and routine medical procedures can become life-threatening. Answer: Increased morbidity and mortality
Answer: Increased morbidity and mortality. The World Health Organization has warned that the
"The overuse of antibiotics has led to the emergence of antibiotic-resistant bacteria, which pose a significant threat to global health. According to a recent report, the number of deaths caused by antibiotic-resistant infections is expected to rise dramatically in the coming years. The World Health Organization has warned that the lack of new antibiotics being developed is a major concern, as it leaves us with limited treatment options for resistant infections." and without critical intervention
: Human negligence, such as not finishing a prescribed course or using antibiotics for viral infections like the common cold, is a major factor. Global Impact
While the threat grows, the arsenal to fight it is shrinking. The 2026 AMR Benchmark report reveals a 35% decrease in antimicrobial research and development projects among large pharmaceutical companies since 2021. Currently, drug-resistant infections contribute to more than one million direct deaths per year, and without critical intervention, this figure is expected to rise dramatically to over eight million annually by 2050.
Do the following statements agree with the information given in the reading passage? In boxes 6–9 on your answer sheet, write: if the statement agrees with the information FALSE if the statement contradicts the information NOT GIVEN if there is no information on this
